Hartmann Young
Senior Business Consultant | Life Science Tools and AI
Vice President of Bioinformatics – 3D Genome Mapping
My client is a genomics innovator seeking a Vice President of Bioinformatics to lead all computational, analytical, and data-driven functions across research, clinical diagnostics, and commercial product development.
The company specializes in 3D genome-mapping technologies and operates both RUO and clinical (CLIA) testing environments, with an accelerating focus on commercial adoption, scaling LDTs, and data-powered precision medicine.
Role Overview The VP of Bioinformatics will define and scale the company’s bioinformatics strategy across algorithms, pipelines, clinical reporting, and data products.
Key Responsibilities
Own and evolve the company’s bioinformatics strategy, spanning research, clinical workflows, data architecture, and product integration.
Lead the development, optimization, and validation of analytical pipelines supporting 3D genomics, structural variant detection, and multi-omic applications.
Build, scale, and mentor a high-performing bioinformatics organization, including computational biology, data science, and software engineering teams.
Drive data monetization initiatives, leveraging clinical, RUO, and biopharma datasets to create new analytical products and insights.
Ensure regulatory-grade bioinformatics operations, supporting CLIA testing, reporting accuracy, quality systems, and reimbursement pathways.
Key Requirements
Proven track record leading and scaling bioinformatics teams in genomics, diagnostics, or precision medicine.
Deep expertise in computational biology, structural variants, or genome mapping; experience in emerging or complex genomic technologies is preferred.
Strong background in clinical diagnostics, LDT development, and regulated environments (CLIA, CAP, quality systems).
Experience in 0→1 environments, building new pipelines, systems, and teams in small or high-growth companies.
Strategic leadership ability with hands‑on technical depth; comfortable partnering cross‑functionally across scientific, clinical, and commercial groups.
#J-18808-Ljbffr
My client is a genomics innovator seeking a Vice President of Bioinformatics to lead all computational, analytical, and data-driven functions across research, clinical diagnostics, and commercial product development.
The company specializes in 3D genome-mapping technologies and operates both RUO and clinical (CLIA) testing environments, with an accelerating focus on commercial adoption, scaling LDTs, and data-powered precision medicine.
Role Overview The VP of Bioinformatics will define and scale the company’s bioinformatics strategy across algorithms, pipelines, clinical reporting, and data products.
Key Responsibilities
Own and evolve the company’s bioinformatics strategy, spanning research, clinical workflows, data architecture, and product integration.
Lead the development, optimization, and validation of analytical pipelines supporting 3D genomics, structural variant detection, and multi-omic applications.
Build, scale, and mentor a high-performing bioinformatics organization, including computational biology, data science, and software engineering teams.
Drive data monetization initiatives, leveraging clinical, RUO, and biopharma datasets to create new analytical products and insights.
Ensure regulatory-grade bioinformatics operations, supporting CLIA testing, reporting accuracy, quality systems, and reimbursement pathways.
Key Requirements
Proven track record leading and scaling bioinformatics teams in genomics, diagnostics, or precision medicine.
Deep expertise in computational biology, structural variants, or genome mapping; experience in emerging or complex genomic technologies is preferred.
Strong background in clinical diagnostics, LDT development, and regulated environments (CLIA, CAP, quality systems).
Experience in 0→1 environments, building new pipelines, systems, and teams in small or high-growth companies.
Strategic leadership ability with hands‑on technical depth; comfortable partnering cross‑functionally across scientific, clinical, and commercial groups.
#J-18808-Ljbffr